메뉴 건너뛰기




Volumn 31, Issue 6, 2012, Pages 578-582

Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection

Author keywords

Adolescent; Nucleotide; Resistance; Treatment

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PLACEBO; VIRUS DNA;

EID: 84861530778     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318255ffe7     Document Type: Article
Times cited : (20)

References (7)
  • 1
    • 0037468406 scopus 로고    scopus 로고
    • Adefovir Dipivoxil 438 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
    • Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir Dipivoxil 438 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med. 2003;348:800-807.
    • (2003) N Engl J Med , vol.348 , pp. 800-807
    • Hadziyannis, S.J.1    Tassopoulos, N.C.2    Heathcote, E.J.3
  • 2
    • 0037468421 scopus 로고    scopus 로고
    • Adefovir Dipivoxil 437 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    • Marcellin P, Chang TT, Lim SG, et al. Adefovir Dipivoxil 437 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med. 2003;348:808-816.
    • (2003) N Engl J Med , vol.348 , pp. 808-816
    • Marcellin, P.1    Chang, T.T.2    Lim, S.G.3
  • 3
    • 46249118136 scopus 로고    scopus 로고
    • Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B
    • Jonas MM, Kelly D, Pollack H, et al. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to
    • (2008) Hepatology , vol.47 , pp. 1863-1871
    • Jonas, M.M.1    Kelly, D.2    Pollack, H.3
  • 4
    • 33644524424 scopus 로고    scopus 로고
    • Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B
    • Sokal EM, Kelly DA, Mizerski J, et al. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology. 2006;43:225-232.
    • (2006) Hepatology , vol.43 , pp. 225-232
    • Sokal, E.M.1    Kelly, D.A.2    Mizerski, J.3
  • 5
    • 0031969612 scopus 로고    scopus 로고
    • Interferon alfa therapy for chronic hepatitis B in children: A multinational randomized controlled trial
    • Sokal EM, Conjeevaram HS, Roberts EA, et al. Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology. 1998;114:988-995.
    • (1998) Gastroenterology , vol.114 , pp. 988-995
    • Sokal, E.M.1    Conjeevaram, H.S.2    Roberts, E.A.3
  • 6
    • 0031867388 scopus 로고    scopus 로고
    • Interferon: A meta-analysis of published studies in pediatric chronic hepatitis B
    • Vajro P, Migliaro F, Fontanella A, et al. Interferon: a meta-analysis of published studies in pediatric chronic hepatitis B. Acta Gastroenterol Belg. 1998;61:219-223.
    • (1998) Acta Gastroenterol Belg , vol.61 , pp. 219-223
    • Vajro, P.1    Migliaro, F.2    Fontanella, A.3
  • 7
    • 0035080735 scopus 로고    scopus 로고
    • Impact of chronic hepatitis B and interferon-alpha therapy on growth of children
    • Comanor L, Minor J, Conjeevaram HS, et al. Impact of chronic hepatitis B and interferon-alpha therapy on growth of children. J Viral Hepat. 2001;8:139-147.
    • (2001) J Viral Hepat , vol.8 , pp. 139-147
    • Comanor, L.1    Minor, J.2    Conjeevaram, H.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.